NCT02860052View on ClinicalTrials.gov

SB208 for the Treatment of Tinea Pedis

PHASE2CompletedINTERVENTIONAL
Enrollment

222

Participants

Timeline

Start Date

July 19, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

February 1, 2017

Conditions
Tinea Pedis
Interventions
DRUG

SB208 2%

Apply once daily to one or both feet for 14 days

DRUG

SB208 4%

Apply once daily to one or both feet for 14 days

DRUG

SB208 16%

Apply once daily to one or both feet for 14 days

DRUG

Vehicle Gel

Apply once daily to one or both feet for 14 days

Trial Locations (1)

Unknown

Instituto Dermatológico y Cirugía de Piel,, Santo Domingo

All Listed Sponsors
lead

Novan, Inc.

INDUSTRY

NCT02860052 - SB208 for the Treatment of Tinea Pedis | Biotech Hunter | Biotech Hunter